1. aim: create panc cancer webinar series to show and discuss best practice/controversy and to bridge gap between specialist and non specialist care in the UK
2. 5 webinars - one hour each. 1-3 spearkers; defined topic each webinar. can have Q and A each session and if appropriate panel discussion (up to five people on panel possible)
2.1. to coincide with RICOCHET
2.2. PSGBI sponsored ? AUGIS too
2.3. certificate of attendance for each webinar - team can monitor if person is watching or not - person needs to watch for >50 mins to get certificate which is automatically emailed. No to CPD points - expensive. certificate can be used for revalidation/appraisal
2.4. Webinars will be live on a ? Thursday evening, first to coincide with world pancreas day November 19th then ? monthly third thursday
2.5. links can be put on various websites - mylans own educational site; psgbi; augis?
2.6. invite via societies, MDT coorcinators; ricochet network, pcuk/appg/pcrf
3. Webinars
3.1. #1 9/20/2020: Debate - has centralisation been good for pancreatic cancer care across teh United Kingdom?
3.1.1. Introduction - centralisation of pancreatic cancer has had unintended harm
3.1.1.1. KR
3.1.2. Agree - NAT/adj - rates - ? Juan Valle
3.1.2.1. juan
3.1.3. How to engage secondary care - the physicians view
3.1.3.1. Vikram
3.1.4. How to engage secondary care - the CNS' view
3.1.4.1. Vicki HS
3.1.5. The patients view and importance of RICOCHET: PCUK
3.1.5.1. nned to ask pcuk
3.2. #2 16/12/2020: Missed opportunity: Treatment of PEI more effective than surgery or chemotherapy?
3.2.1. Why do patients with pancreatic cancer develop PEI and how relevant is it
3.2.1.1. Enrique
3.2.2. Benefits of PERT in pancreatic cancer’
3.2.2.1. KR
3.2.3. National audit: RICOCHET results
3.2.3.1. rich w
3.3. #3 21/1/2021: optimal pathway for non metastatic pancreatic cancers
3.3.1. Resectable cancer: Debate
3.3.1.1. Direct to surgery KR or Nicolo D'L
3.3.1.1.1. not yet sure
3.3.1.2. NAT Andy S
3.3.1.2.1. andy
3.3.2. management of BR and LA cancer Kito F
3.3.2.1. kito
3.3.3. National audit: RICOCHET results: Rich Wilkin
3.3.3.1. Siobhan
3.3.4. CHAIR MARK TAYLOR
3.4. #4 17/2/2021: Non-surgical therapies in pancreatic cancer
3.4.1. Chemotherapy overview ? Dan Palmer
3.4.1.1. dan
3.4.2. Radiotherapy overview ? James Good or Maria H or Som
3.4.2.1. james
3.4.3. Novel and emerging therapies ? Sanjay P
3.4.3.1. IRE
3.4.3.2. Oligometastatic cancer
3.4.3.3. have asked sanjay
3.5. #5 18/3/2021: Novel strategies in pancreatic cancer ? CHANGE THIS TO HOW TO IMPROVE THE MDT AND MOVE STEVE P INTO SESSION 4
3.5.1. Screening ? Steve Pereira
3.5.1.1. steve
3.5.2. Surveillance: what is the evidence? JMH or Marc B or Daamen?
3.5.2.1. I've asked Lois - no reply from marc b
3.5.3. Precision medicine and personalised care - David Chang?
3.5.3.1. invited 25th Jan
3.5.4. Standardisation of radiology reporting across the UK
3.5.4.1. John Moir invited 25th jan